Our Research
Discover our recent findings, catch up with news, and review in-depth resources.
Case Studies
Measuring What Matters: High-Precision Plasma Protein Binding Assessment for Highly Bound Compounds Under ICH M12
Resolian developed high-precision LC-MS/MS methods and optimised equilibrium dialysis workflows for plasma protein binding assessment of highly protein-bound compounds, Supporting ICH M12 regulatory expectations across five species.
Videos
Resolian Sandwich UK Analytical Sciences Lab Tour
Take a virtual tour of Resolian’s Sandwich lab: analytical and materials science expertise spanning solid state, physical properties, and foreign matter analysis.
Case Studies
Solving Carboplatin: A Novel LC-MS/MS Assay for Intact Drug Quantitation in Human Plasma
Resolian developed and validated (following ICH-M10) a high-throughput and robust LC MS/MS method for quantifying intact carboplatin in human plasma, overcoming long-standing challenges around isotopic interference, protein binding, and chromatographic retention.
Case Studies
Surface Energy and Sucrose: Why Milling Method Matters More Than Particle Size
How does milling method affect pharmaceutical powder surfaces? Resolian’s iGC-SEA analysis of sucrose reveals that processing route influences surface energy more significantly than particle size alone.
Case Studies
Understanding Nanoparticle Surfaces: A New Analytical Approach for Nanomedicine Research
Discover how Resolian used iGC-SEA to characterise polymer nanoparticle surface energy for Loughborough University, generating new insights into protein corona formation and nanomedicine development.
Blog
USP 665 and USP 1665: What Pharma Manufacturers Need to Know
USP and USP are now mandatory for pharma and biopharma manufacturers using plastic components. Learn what compliance requires and how Resolian’s E&L experts can help.
